STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Inspire Medical Systems (NYSE: INSP), a pioneer in obstructive sleep apnea medical technology, has announced its upcoming participation in the BofA Securities 2025 Health Care Conference.

The company's management team is scheduled to deliver their presentation on Tuesday, May 13, 2025, at 2:20 p.m. Eastern Time. Investors and interested parties can access the presentation through a live webcast.

Key Details:

  • Event: BofA Securities 2025 Health Care Conference
  • Date: May 13, 2025
  • Time: 2:20 p.m. ET
  • Access: Live webcast available
  • Replay: Available for two weeks post-presentation in the Event Archive section of Inspire's Investor website
Loading...
Loading translation...

Positive

  • Increased visibility through participation in a major healthcare conference
  • Live webcast availability increases investor accessibility and transparency

Negative

  • None.

MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025.

Inspire is scheduled to present at 2:20 p.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443


FAQ

When is Inspire Medical Systems (INSP) presenting at the BofA Securities 2025 Health Care Conference?

Inspire Medical Systems (INSP) is scheduled to present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 2:20 p.m. Eastern Time.

How can I watch Inspire Medical Systems' (INSP) presentation at the BofA 2025 Healthcare Conference?

The presentation will be available via live webcast, and a replay will be accessible for two weeks afterward in the Event Archive section of Inspire's Investor website at investors.inspiresleep.com.

What type of medical technology does Inspire Medical Systems (INSP) specialize in?

Inspire Medical Systems specializes in developing and commercializing innovative, minimally invasive solutions specifically for patients with obstructive sleep apnea.

Where can I find the replay of Inspire Medical Systems' (INSP) BofA Securities conference presentation?

The presentation replay will be available in the Event Archive section of Inspire's Investor website at investors.inspiresleep.com for two weeks following the May 13, 2025 presentation.
Inspire Medical

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Latest SEC Filings

INSP Stock Data

3.79B
28.71M
1.14%
117.62%
7.94%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GOLDEN VALLEY